Leadership Insights: The ROI of the MDS Baseline Assessment

June 20, 2025

In today’s health care environment, nursing home providers are navigating an increasingly complex landscape—marked by rapidly evolving regulations, shrinking reimbursements, and greater scrutiny from oversight agencies. In the midst of these challenges, ensuring the accuracy, consistency, and strategic timing of your Minimum Data Set (MDS) assessments is not just important—it’s essential.

The MDS isn’t merely a documentation tool—it’s the data engine behind every CMS-driven program that influences how your organization is reimbursed, rated, and reviewed. From the Five-Star Quality Rating System and the SNF Quality Reporting Program (QRP) to SNF Value-Based Purchasing (VBP) and PDPM, the quality of your MDS data directly impacts performance. It also plays a critical role in compliance initiatives such as 5-Claim Probe and Educate audits, schizophrenia diagnosis scrutiny, and Additional Documentation Requests (ADRs).

Even a small misstep in the assessment process can result in delayed payments, lowered star ratings, and increased survey citations. That’s why it’s never been more important for providers to take a proactive approach in evaluating the integrity and reliability of their MDS systems.

To explore this further, Lisa Thomson, Chief Operating Officer at Pathway Health, connected with Scott Hoekel, Director of Reimbursement and Education, for a candid conversation about the impact and ROI of the Pathway Health MDS Baseline Assessment.

Lisa: When specifically thinking about the potential financial impact, how does MDS accuracy affect a provider’s bottom line?

Scott: It’s huge. MDS accuracy directly drives PDPM (Medicare) and Medicaid Case Mix payments. If you have coding errors or documentation gaps, you’re looking at lost revenue, delayed payments, or even recoupments. That’s why precise and timely MDS completion is non-negotiable.

Lisa: What about the impact on compliance and audit risks?

Scott: That’s another area that leaders should consider. With CMS initiatives like the 5-Claim Probe and Educate, ADRs, and diagnosis-specific reviews—particularly around schizophrenia—the pressure is on. One misstep can lead to financial penalties and reputation harm. Our assessments help identify and fix those risks before they become real problems.

Lisa: How do quality measures tie into MDS accuracy?

Scott: MDS data feeds directly into:

The Five-Star Quality Rating System
The SNF Quality Reporting Program (QRP)
Value-Based Purchasing (VBP)

Poor data equals poor scores, which can mean fewer referrals, lower census, and lost revenue opportunities. An MDS Baseline Assessment helps protect and improve those publicly reported outcomes.

Lisa: Please share the ke areas that make Pathway Health’s MDS Baseline Assessment unique?

Scott: Several key things:

  • Expertise in Clinical Reimbursement: Our assessments are led by experienced specialists who know both the clinical and regulatory sides.
  • Comprehensive Two-Day Onsite Review: We provide a deep dive into your current MDS/RAI processes, staff competency, and risk exposure.
  • Real-Time Education: We coach your team onsite—no delays, no webinars. This is immediate learning in the context of real work.
  • Actionable Insights: You walk away with a findings report filled with clear, prioritized recommendations and guidance for sustained improvement.

Lisa: Staffing turnover is a constant challenge. How does the MDS Baseline Assessment support stability?

Scott: Frequent staff changes almost always lead to inconsistencies in documentation. Our assessment helps reinforce standardized practices, clarify team roles, and reduce onboarding time for new team members. It stabilizes your processes and gives your team more confidence.

Lisa: Please summarize the MDS Baseline Assessment ROI that leaders can expect?

Scott: Absolutely. See the below table for a high-level overview.

Lisa: For leaders evaluating whether to invest in this—what’s the most important takeaway?

Scott: It’s simple: This isn’t just a cost—it’s an investment in your future. With payer complexity increasing and regulatory eyes on every detail, assuming your MDS process is solid is a risk you can’t afford. We help you catch vulnerabilities before CMS or your fiscal intermediary does.

A leader who commits to a baseline MDS assessment is choosing stability, optimization, and long-term success.

Lisa: Please share any final thoughts.

Scott: Accuracy = profitability. When your documentation is strong, your revenue, compliance, and care quality follow. A Pathway Health MDS Baseline Assessment gives you the foundation to thrive.

Helpful Resources:

Consulting Solutions: MDS Baseline Assessment

Pathway Health’s two-day onsite MDS Baseline Assessment delivers a comprehensive, real-time evaluation of your facility’s MDS processes. Led by clinical reimbursement specialists, it identifies vulnerabilities, enhances staff competencies, and ensures sustainable documentation practices.

Leadership ROI at a Glance

Download the MDS Baseline Assessment overview and learn more!

We provide MDS solutions and professionals to support your team and compliance strategies. Contact us to learn more.

Posted in ,